Skrining Potensi Essential Oil Cananga odorata dalam Penghambatannya Terhadap ACE II dan TMPRSS2 sebagai Anti Covid-19: Pendekatan In Silico
Article Sidebar
Main Article Content
Abstract
COVID-19 is a disease caused by viruses of the coronavirus class that are known to enter humans through the Angiotensin Coverting Enzyme (ACE II) receptor protein and transmembrane serine protease (TMPRSS 2). COVID-19 has become a pandemic, so it requires an agent that acts as an anti-Covid-19. Cananga odora is an herb that contains EO (Essential Oils) and is widely grown in Indonesia. EO are known to have antiviral potential.
This study aims to explore the potential of EO from C.odora using a molecular docking approach by measuring its inhibition of ACE II (Q9BYF1) and TMPRSS2 (7MEQ). The inhibitory potential was calculated from the binding affinity using Pyrex Autodock Vina software. The docking results are then visualized using Biovia Discovery Studio and PyMOL. Prediction of physicochemical and pharmacokinetic profiles through pKCsm web. The docking results showed that geranyl acetate inhibited ACE II at Lys 562 with a gibs energy of -7.5 kcal. The
best inhibition of TMPRSS2 by cedrole with energy gibs -6.2 kcal/mol via Pro 375. The active compound C. odorata has a different inhibitory mechanism from the control (chloroquine). The results of the in silico test predict the pharmacokinetic profile of EO from C.odora geranil asetat which has good absorption, distribution, metabolism and excretion values and is non-toxic, and cedrole can cross the blood brain barier.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright and Attribution:
Jurnal Biosaintropis (Bioscience-Tropici s licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY). The work has not been published before (except in the form of an abstract or part of a published lecture or thesis) and it is not under consideration for publication elsewhere. When the manuscript is accepted for publication in this journal, the authors agree to automatic transfer of the copyright to the publisher.
Permissions:
Authors wishing to include figures, tables, or text passages that have already been published elsewhere and by other authors are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from one of the authors.
Ethical matters:
Experiments with animals or involving human patients must have had prior approval from the appropriate ethics committee. A statement to this effect should be provided within the text at the appropriate place. Experiments involving plants or microorganisms taken from countries other than the authors™ own must have had the correct authorization for this exportation.